These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 20885081)

  • 1. Amyloid imaging using high-field magnetic resonance.
    Amatsubo T; Yanagisawa D; Morikawa S; Taguchi H; Tooyama I
    Magn Reson Med Sci; 2010; 9(3):95-9. PubMed ID: 20885081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloid imaging using fluorine-19 magnetic resonance imaging ((19)F-MRI).
    Tooyama I; Yanagisawa D; Taguchi H; Kato T; Hirao K; Shirai N; Sogabe T; Ibrahim NF; Inubushi T; Morikawa S
    Ageing Res Rev; 2016 Sep; 30():85-94. PubMed ID: 26772439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular targeting of Alzheimer's amyloid plaques for contrast-enhanced magnetic resonance imaging.
    Poduslo JF; Wengenack TM; Curran GL; Wisniewski T; Sigurdsson EM; Macura SI; Borowski BJ; Jack CR
    Neurobiol Dis; 2002 Nov; 11(2):315-29. PubMed ID: 12505424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and chemical synthesis of a magnetic resonance contrast agent with enhanced in vitro binding, high blood-brain barrier permeability, and in vivo targeting to Alzheimer's disease amyloid plaques.
    Poduslo JF; Curran GL; Peterson JA; McCormick DJ; Fauq AH; Khan MA; Wengenack TM
    Biochemistry; 2004 May; 43(20):6064-75. PubMed ID: 15147190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Amyloid-plaque imaging of the brain using PET].
    Ossenkoppele R; Tolboom N; Pijnenburg YA; Lammertsma AA; Scheltens P; van Berckel BN
    Ned Tijdschr Geneeskd; 2011; 155():A2981. PubMed ID: 21586182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gadolinium-complexed Aβ-binding contrast agents for MRI diagnosis of Alzheimer's Disease.
    Matharu B; Spencer N; Howe F; Austen B
    Neuropeptides; 2015 Oct; 53():63-70. PubMed ID: 26234669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrast Enhanced Magnetic Resonance Imaging of Amyloid-β Plaques in a Murine Alzheimer's Disease Model.
    Sulheim E; WiderØe M; Bäck M; Nilsson KPR; Hammarström P; Nilsson LNG; Davies CL; Åslund AKO
    J Alzheimers Dis; 2023; 93(2):411-419. PubMed ID: 37038807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorine-18 radiolabeled heterocycles as PET tracers for imaging β-amyloid plaques in Alzheimer's disease.
    Zeng F; Goodman MM
    Curr Top Med Chem; 2013; 13(8):909-19. PubMed ID: 23590167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Technology Insight: imaging amyloid plaques in the living brain with positron emission tomography and MRI.
    Huddleston DE; Small SA
    Nat Clin Pract Neurol; 2005 Dec; 1(2):96-105. PubMed ID: 16932505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visualizing pathology deposits in the living brain of patients with Alzheimer's disease.
    Kepe V; Huang SC; Small GW; Satyamurthy N; Barrio JR
    Methods Enzymol; 2006; 412():144-60. PubMed ID: 17046657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of Alzheimer's amyloid in transgenic mice using magnetic resonance microimaging.
    Wadghiri YZ; Sigurdsson EM; Sadowski M; Elliott JI; Li Y; Scholtzova H; Tang CY; Aguinaldo G; Pappolla M; Duff K; Wisniewski T; Turnbull DH
    Magn Reson Med; 2003 Aug; 50(2):293-302. PubMed ID: 12876705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gd-nanoparticles functionalization with specific peptides for ß-amyloid plaques targeting.
    Plissonneau M; Pansieri J; Heinrich-Balard L; Morfin JF; Stransky-Heilkron N; Rivory P; Mowat P; Dumoulin M; Cohen R; Allémann É; Tόth É; Saraiva MJ; Louis C; Tillement O; Forge V; Lux F; Marquette C
    J Nanobiotechnology; 2016 Jul; 14(1):60. PubMed ID: 27455834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microglia contributes to plaque growth by cell death due to uptake of amyloid β in the brain of Alzheimer's disease mouse model.
    Baik SH; Kang S; Son SM; Mook-Jung I
    Glia; 2016 Dec; 64(12):2274-2290. PubMed ID: 27658617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multimodal Imaging in Rat Model Recapitulates Alzheimer's Disease Biomarkers Abnormalities.
    Parent MJ; Zimmer ER; Shin M; Kang MS; Fonov VS; Mathieu A; Aliaga A; Kostikov A; Do Carmo S; Dea D; Poirier J; Soucy JP; Gauthier S; Cuello AC; Rosa-Neto P
    J Neurosci; 2017 Dec; 37(50):12263-12271. PubMed ID: 29097597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of amyloid plaques targeted by bifunctional USPIO in Alzheimer's disease transgenic mice using magnetic resonance microimaging.
    Wadghiri YZ; Li J; Wang J; Hoang DM; Sun Y; Xu H; Tsui W; Li Y; Boutajangout A; Wang A; de Leon M; Wisniewski T
    PLoS One; 2013; 8(2):e57097. PubMed ID: 23468919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Novel Magnetic Nanoparticle for Early Detection of Amyloid Plaques in Alzheimer's Disease.
    Zeng J; Wu J; Li M; Wang P
    Arch Med Res; 2018 May; 49(4):282-285. PubMed ID: 30266531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel 18F-labeled pyridyl benzofuran derivative for imaging of β-amyloid plaques in Alzheimer's brains.
    Cheng Y; Ono M; Kimura H; Kagawa S; Nishii R; Saji H
    Bioorg Med Chem Lett; 2010 Oct; 20(20):6141-4. PubMed ID: 20817524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging beta amyloid aggregation and iron accumulation in Alzheimer's disease using quantitative susceptibility mapping MRI.
    Gong NJ; Dibb R; Bulk M; van der Weerd L; Liu C
    Neuroimage; 2019 May; 191():176-185. PubMed ID: 30739060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorescence Chemicals To Detect Insoluble and Soluble Amyloid-β Aggregates.
    Lee D; Kim SM; Kim HY; Kim Y
    ACS Chem Neurosci; 2019 Jun; 10(6):2647-2657. PubMed ID: 31009195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and amyloid plaque targeting ability of a novel peptide-based magnetic resonance contrast agent in wild-type and Alzheimer's disease transgenic mice.
    Kandimalla KK; Wengenack TM; Curran GL; Gilles EJ; Poduslo JF
    J Pharmacol Exp Ther; 2007 Aug; 322(2):541-9. PubMed ID: 17505020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.